Mass-selected site-specific core-fucosylation of serum proteins in hepatocellular carcinoma

Journal of Proteome Research

Volumn 14, Issue 11, 2015, Pages 4876-4884

  Yin, Haidi ^a   Tan, Zhijing ^a   Wu, Jing ^a   Zhu, Jianhui ^a   Shedden, Kerby A ^b   Marrero, Jorge ^c   Lubman, David M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

alcohol related HCC; Core fucosylation; hepatitis C virus related HCC; hepatocellular carcinoma; site specific

Indexed keywords

AGGLUTININ; ALCOHOL; FIBRONECTIN; PLASMA PROTEIN; VASCULAR ENDOTHELIAL CADHERIN; BIOLOGICAL MARKER; CADHERIN; FUCOSE; LEUKOCYTE ANTIGEN; TRYPSIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CORE FUCOSYLATION; FEMALE; FUCOSYLATION; HEPATITIS C VIRUS; HUMAN; LENTIL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; UPREGULATION; ALCOHOLISM; AMINO ACID SEQUENCE; BLOOD; CANCER STAGING; CARCINOMA, HEPATOCELLULAR; CHEMISTRY; COMPLICATION; GENETICS; HEPATITIS B; HEPATITIS C; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY; PEPTIDE MAPPING; PROTEIN DEGRADATION; PROTEIN PROCESSING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALCOHOLISM; AMINO ACID SEQUENCE; ANTIGENS, CD; BIOMARKERS; BLOOD PROTEINS; CADHERINS; CARCINOMA, HEPATOCELLULAR; FEMALE; FIBRONECTINS; FUCOSE; HEPATITIS B; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE ANNOTATION; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; PEPTIDE MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; TRYPSIN;

EID: 84946866536     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/acs.jproteome.5b00718     Document Type: Article

References (33)

1. Kamangar, F.; Dores, G. M.; Anderson, W. F. Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world J. Clin. Oncol. 2006, 24, 2137-2150 10.1200/JCO.2005.05.2308
2. El-Serag, H. B. CURRENT CONCEPTS Hepatocellular Carcinoma N. Engl. J. Med. 2011, 365, 1118-1127 10.1056/NEJMra1001683
3. Llovet, J. M.; Burroughs, A.; Bruix, J. Hepatocellular carcinoma Lancet 2003, 362, 1907-1917 10.1016/S0140-6736(03)14964-1
4. Trevisani, F.; D'Intino, P. E.; Morselli-Labate, A. M.; Mazzella, G.; Accogli, E.; Caraceni, P.; Domenicali, M.; De Notariis, S.; Roda, E.; Bernardi, M. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status J. Hepatol. 2001, 34, 570-575 10.1016/S0168-8278(00)00053-2
5. Marrero, J. A.; Feng, Z. D.; Wang, Y. H.; Nguyen, M. H.; Befeler, A. S.; Roberts, L. R.; Reddy, K. R.; Harnois, D.; Llovet, J. M.; Normolle, D.; Dalhgren, J.; Chia, D.; Lok, A. S.; Wagner, P. D.; Srivastava, S.; Schwartz, M. alpha-Fetoprotein, Des-gamma Carboxyprothrombin, and Lectin-Bound alpha-Fetoprotein in Early Hepatocellular Carcinoma Gastroenterology 2009, 137, 110-118 10.1053/j.gastro.2009.04.005
6. Wu, J.; Zhu, J. H.; Yin, H. D.; Buckanovich, R. J.; Lubman, D. M. Analysis of Glycan Variation on Glycoproteins from Serum by the Reverse Lectin-Based ELISA Assay J. Proteome Res. 2014, 13, 2197-2204 10.1021/pr401061c
7. Li, Q. K.; Gabrielson, E.; Zhang, H. Application of glycoproteomics for the discovery of biomarkers in lung cancer Proteomics: Clin. Appl. 2012, 6, 244-256 10.1002/prca.201100042
8. Pompach, P.; Brnakova, Z.; Sanda, M.; Wu, J.; Edwards, N.; Goldman, R. Site-specific Glycoforms of Haptoglobin in Liver Cirrhosis and Hepatocellular Carcinoma Mol. Cell. Proteomics 2013, 12, 1281-1293 10.1074/mcp.M112.023259
9. Lin, Z. X.; Yin, H. D.; Lo, A.; Ruffin, M. T.; Anderson, M. A.; Simeone, D. M.; Lubman, D. M. Label-free relative quantification of alpha-2-macroglobulin site-specific core-fucosylation in pancreatic cancer by LC-MS/MS Electrophoresis 2014, 35, 2108-2115 10.1002/elps.201300376
10. Tan, Z. J.; Yin, H. D.; Nie, S.; Lin, Z. X.; Zhu, J. H.; Ruffin, M. T.; Anderson, M. A.; Simeone, D. M.; Lubman, D. M. Large-Scale Identification of Core-Fucosylated Glycopeptide Sites in Pancreatic Cancer Serum Using Mass Spectrometry J. Proteome Res. 2015, 14, 1968-1978 10.1021/acs.jproteome.5b00068
11. Nie, S.; Lo, A.; Wu, J.; Zhu, J. H.; Tan, Z. J.; Simeone, D. M.; Anderson, M. A.; Shedden, K. A.; Ruffin, M. T.; Lubman, D. M. Glycoprotein Biomarker Panel for Pancreatic Cancer Discovered by Quantitative Proteomics Analysis J. Proteome Res. 2014, 13, 1873-1884 10.1021/pr400967x
12. Ahn, J. M.; Sung, H. J.; Yoon, Y. H.; Kim, B. G.; Yang, W. S.; Lee, C.; Park, H. M.; Kim, B. J.; Kim, B. G.; Lee, S. Y.; An, H. J.; Cho, J. Y. Integrated Glycoproteomics Demonstrates Fucosylated Serum Paraoxonase 1 Alterations in Small Cell Lung Cancer Mol. Cell. Proteomics 2014, 13, 30-48 10.1074/mcp.M113.028621
13. Lee, H. J.; Cha, H. J.; Lim, J. S.; Lee, S. H.; Song, S. Y.; Kim, H.; Hancock, W. S.; Yoo, J. S.; Paik, Y. K. Abundance-Ratio-Based Semiquantitative Analysis of Site-Specific N-Linked Glycopeptides Present in the Plasma of Hepatocellular Carcinoma Patients J. Proteome Res. 2014, 13, 2328-2338 10.1021/pr4011519
14. Zhu, J. H.; Lin, Z. X.; Wu, J.; Yin, H. D.; Dai, J. L.; Feng, Z. D.; Marrero, J.; Lubman, D. M. Analysis of Serum Haptoglobin Fucosylation in Hepatocellular Carcinoma and Liver Cirrhosis of Different Etiologies J. Proteome Res. 2014, 13, 2986-2997 10.1021/pr500128t
15. Nakagawa, T.; Miyoshi, E.; Yakushijin, T.; Hiramatsu, N.; Igura, T.; Hayashi, N.; Taniguchi, N.; Kondo, A. Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients J. Proteome Res. 2008, 7, 2222-2233 10.1021/pr700841q
16. Toyoda, H.; Kumada, T.; Tada, T.; Kaneoka, Y.; Maeda, A.; Kanke, F.; Satomura, S. Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein < 20 ng/mL Cancer Sci. 2011, 102, 1025-31 10.1111/j.1349-7006.2011.01875.x
17. Liu, Y. S.; He, J. T.; Li, C.; Benitez, R.; Fu, S.; Marrero, J.; Lubman, D. M. Identification and Confirmation of Biomarkers Using an Integrated Platform for Quantitative Analysis of Glycoproteins and Their Glycosylations J. Proteome Res. 2010, 9, 798-805 10.1021/pr900715p
18. Yin, H. D.; Lin, Z. X.; Nie, S.; Wu, J.; Tan, Z. J.; Zhu, J. H.; Dai, J. L.; Feng, Z. D.; Marrero, J.; Lubman, D. M. Mass-Selected Site-Specific Core-Fucosylation of Ceruloplasmin in Alcohol-Related Hepatocellular Carcinoma J. Proteome Res. 2014, 13, 2887-2896 10.1021/pr500043k
19. Fanayan, S.; Hincapie, M.; Hancock, W. S. Using lectins to harvest the plasma/serum glycoproteome Electrophoresis 2012, 33, 1746-1754 10.1002/elps.201100567
20. Morgan, T. R.; Mandayam, S.; Jamal, M. M. Alcohol and hepatocellular carcinoma Gastroenterology 2004, 127, S87-96 10.1053/j.gastro.2004.09.020
21. Riener, M. O.; Stenner, F.; Liewen, H.; Soll, C.; Breitenstein, S.; Pestalozzi, B. C.; Samaras, P.; Probst-Hensch, N.; Hellerbrand, C.; Mullhaupt, B.; Clavien, P. A.; Bahra, M.; Neuhaus, P.; Wild, P.; Fritzsche, F.; Moch, H.; Jochum, W.; Kristiansen, G. Golgi Phosphoprotein 2 (GOLPH2) Expression in Liver Tumors and Its Value as a Serum Marker in Hepatocellular Carcinomas Hepatology 2009, 49, 1602-1609 10.1002/hep.22843
22. Mao, Y. L.; Yang, H. Y.; Xu, H. F.; Lu, X.; Sang, X. T.; Du, S. D.; Zhao, H. T.; Chen, W.; Xu, Y.; Chi, T. Y.; Yang, Z. Y.; Cai, J. Q.; Li, H.; Chen, J. G.; Zhong, S. X.; Mohanti, S. R.; Lopez-Soler, R.; Millis, J. M.; Huang, J. F.; Zhang, H. B. Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma Gut 2010, 59, 1687-1693 10.1136/gut.2010.214916
23. Marrero, J. A.; Romano, P. R.; Nikolaeva, O.; Steel, L.; Mehta, A.; Fimmel, C. J.; Comunale, M. A.; D'Amelio, A.; Lok, A. S.; Block, T. M. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma J. Hepatol. 2005, 43, 1007-1012 10.1016/j.jhep.2005.05.028
24. Drake, R. R.; Schwegler, E. E.; Malik, G.; Diaz, J.; Block, T.; Mehta, A.; Semmes, O. J. Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers Mol. Cell. Proteomics 2006, 5, 1957-1967 10.1074/mcp.M600176-MCP200
25. Iftikhar, R.; Kladney, R. D.; Havlioglu, N.; Schmitt-Graff, A.; Gusmirovic, I.; Solomon, H.; Luxon, B. A.; Bacon, B. R.; Fimmel, C. J. Disease- and cell-specific expression of GP73 in human liver disease Am. J. Gastroenterol. 2004, 99, 1087-1095 10.1111/j.1572-0241.2004.30572.x
26. Marrero, J. A.; Su, G. L.; Wei, W.; Emick, D.; Conjeevaram, H. S.; Fontana, R. J.; Lok, A. S. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients Hepatology 2003, 37, 1114-1121 10.1053/jhep.2003.50195
27. To, W. S.; Midwood, K. S. Plasma and cellular fibronectin: distinct and independent functions during tissue repair Fibrog. Tissue Repair 2011, 4, 21 10.1186/1755-1536-4-21
28. Essentials of Glycobiology; Varki, A.; Cummings, R. D; Esko, J. D.; Freeze, H. H.; Stanley, P.; Bertozzi, C. R.; Hart, G. W.; Etzler, M. E., Eds.; Cold Spring Harbor Laboratory Press: New York, 2008; p 107.
29. Noda, K.; Miyoshi, E.; Uozumi, N.; Yanagidani, S.; Ikeda, Y.; Gao, C. X.; Suzuki, K.; Yoshihara, H.; Yoshikawa, M.; Kawano, K.; Hayashi, N.; Hori, M.; Taniguchi, N. Gene expression of alpha 1-6 fucosyltransferase in human hepatoma tissues: A possible implication for increased fucosylation of alpha-fetoprotein Hepatology 1998, 28, 944-952 10.1002/hep.510280408
30. Kobayashi, S.; Nouso, K.; Kinugasa, H.; Takeuchi, Y.; Tomoda, T.; Miyahara, K.; Hagihara, H.; Kuwaki, K.; Onishi, H.; Nakamura, S.; Ikeda, F.; Miyake, Y.; Shiraha, H.; Takaki, A.; Yamamoto, K. Clinical utility of serum fucosylated hemopexin in Japanese patients with hepatocellular carcinoma Hepatol. Res. 2012, 42, 1187-1195 10.1111/j.1872-034X.2012.01044.x
31. Benicky, J.; Sanda, M.; Pompach, P.; Wu, J.; Goldman, R. Quantification of Fucosylated Hemopexin and Complement Factor H in Plasma of Patients with Liver Disease Anal. Chem. 2014, 86, 10716-10723 10.1021/ac502727s
32. Lampugnani, M. G.; Orsenigo, F.; Rudini, N.; Maddaluno, L.; Boulday, G.; Chapon, F.; Dejana, E. CCM1 regulates vascular-lumen organization by inducing endothelial polarity J. Cell Sci. 2010, 123, 1073-1080 10.1242/jcs.059329
33. Fry, S. A.; Sinclair, J.; Timms, J. F.; Leathem, A. J.; Dwek, M. V. A targeted glycoproteomic approach identifies cadherin-5 as a novel biomarker of metastatic breast cancer Cancer Lett. 2013, 328, 335-344 10.1016/j.canlet.2012.10.011